The removal came during a Senate committee discussion of Senate Bill 312 that would help IHMC set up subsidiaries.
16h
Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases ---- Amit Munshi ...
Inhibikase Therapeutics (IKT) appointed Mark Iwicki as the company’s CEO, replacing Milton Werner, founder of Inhibikase, effective February ...
Matthews International appoints Thomas Gebhart to board amid proxy battle. Gebhart brings extensive battery and EV industry ...
Lothes is the first American on Fielmann Group’s Management Board, showcasing its commitment to US eyewear customers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback